Lonza

CategoryICSE
Booth No.1D-03
Pavilion
As one of the world’s most renowned companies for contract development and manufacturing, we are recognized for our reliable, high-quality service, our global capacity, our innovative technology platforms, and our extensive experience.
Our broad capabilities span across biologics, small molecules, bioconjugates, and cell and gene therapies. We manage projects from pre-clinical stage through to commercialization, and our expertise covers both drug substance and drug product.

Corporate information

Address 103-0027
Nihonbashi Kato Bldg 9F, 2-1-14 Nihonbashi, Chuo-Ku, Tokyo JAPAN
TEL +81-3-6264-7630
FAX +81-3-6264-7631
URL https://www.lonza.co.jp/
Email pharma-biotech-jp@lonza.com
Product Classification Small molecules (API, intermediates)
Biologics (Mammalian, Microbial)
Cell and gene therapy
Highly potent API
ADCs / Bioconjugates
Particle engineering services
Bioavailability enhancement
Oral drug products and intermediates
Inhalation formulation services
Parenteral drug product services
Expression technologies
Discovery services

Exhibitor Presentation

    April 21(Thu.) 15:30-16:00 【1C】
    Single-sourced partner to accelerate your timeline to market